Vascular Incompetence in Dialysis Patients—Protein‐Bound Uremic Toxins and Endothelial Dysfunction
- 1 May 2011
- journal article
- review article
- Published by Wiley in Seminars in Dialysis
- Vol. 24 (3), 327-337
- https://doi.org/10.1111/j.1525-139x.2011.00925.x
Abstract
Patients with chronic kidney disease (CKD) have a much higher risk of cardiovascular diseases than the general population. Endothelial dysfunction, which participates in accelerated atherosclerosis, is a hallmark of CKD. Patients with CKD display impaired endothelium-dependent vasodilatation, elevated soluble biomarkers of endothelial dysfunction, and increased oxidative stress. They also present an imbalance between circulating endothelial populations reflecting endothelial injury (endothelial microparticles and circulating endothelial cells) and repair (endothelial progenitor cells). Endothelial damage induced by a uremic environment suggests an involvement of uremia-specific factors. Several uremic toxins, mostly protein-bound, have been shown to have specific endothelial toxicity: ADMA, homocysteine, AGEs, and more recently, p-cresyl sulfate and indoxyl sulfate. These toxins, all poorly removed by hemodialysis therapies, share mechanisms of endothelial toxicity: they promote pro-oxidant and pro-inflammatory response and inhibit endothelial repair. This article (i) reviews the evidence for endothelial dysfunction in CKD, (ii) specifies the involvement of protein-bound uremic toxins in this dysfunction, and (iii) discusses therapeutic strategies for lowering uremic toxin concentrations or for countering the effects of uremic toxins on the endothelium.Keywords
This publication has 179 references indexed in Scilit:
- Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient miceNephrology Dialysis Transplantation, 2011
- Aortic PWV in Chronic Kidney Disease: A CRIC Ancillary StudyAmerican Journal of Hypertension, 2010
- Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2Biochemical and Biophysical Research Communications, 2009
- Rosuvastatin and Cardiovascular Events in Patients Undergoing HemodialysisNew England Journal of Medicine, 2009
- The relationship between circulating endothelial microparticles and arterial stiffness and atherosclerosis in children with chronic kidney diseaseNephrology Dialysis Transplantation, 2009
- Arginine, arginine analogs and nitric oxide production in chronic kidney diseaseNature Clinical Practice Nephrology, 2006
- Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: Results of the HOPE StudyKidney International, 2004
- Review on uremic toxins: Classification, concentration, and interindividual variabilityKidney International, 2003
- Anti-angiogenic effects of homocysteine on cultured endothelial cellsBiochemical and Biophysical Research Communications, 2002
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993